The gastric acid blocker Vonoprazan fumarate will be studied by Dr. Reddy's with approval from the CDSCO Panel.

Published Date: 02 Jun 2023

New Delhi: The Central Drug Standard Control's Subject Expert Committee (SEC) is operating in accordance with the findings of the bioequivalence (BE) study report.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Common intracellular toxin could help fight leukemia

2.

CAR T-Cell Therapy Shows Promise in Mantle Cell Lymphoma

3.

Scholastic performance is a key concern for young cancer patients, study finds

4.

AACR: American Association for Cancer Research

5.

Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot